Skip to main content

News

ADHD Awareness Month – Message from Purdue Pharma (Canada)

Published on October 4, 2019

October is ADHD Awareness Month. According to the Centre for ADHD Awareness, Canada, more than…

Read More

AKYNZEO ® Oral now covered by the Ontario, Quebec and Non-Insured Health Benefits

Published on July 10, 2019

Pickering, Ontario (July 10, 2019) – Purdue Pharma (Canada) is pleased to announce that AKYNZEO®…

Read More

Message from Purdue Pharma (Canada)

Published on April 9, 2019

The Canadian Cancer Society has designated April Cancer Awareness Month.  According to the Society, cancer…

Read More

FOQUEST® RECEIVES APPROVAL FOR EXPANDED INDICATION FOR CHILDREN AND ADOLESCENTS WITH ADHD

Published on March 12, 2019

First and only methylphenidate product approved in Canada that provides control of ADHD symptoms throughout…

Read More

ARCHIVE

2019
2018
2017
2016
2015
2014
2013
2012

For all media inquiries, please contact:

media@purdue.ca

↓